InvestorsHub Logo
Followers 5
Posts 1919
Boards Moderated 1
Alias Born 07/04/2017

Re: 1234jklm post# 79715

Thursday, 01/11/2018 10:08:42 PM

Thursday, January 11, 2018 10:08:42 PM

Post# of 144814
Choosing and contracting a CRO comes easy enough.

Should be the least of your worries. Its certainly become mine since the recent mishaps.

I, like most here, would agree that KW has more than likely already been in talks with one. Perhaps he’s waiting for the appropriate time to contract and spend the money. He certainly has reason to. For example, ViraSure’s hand-off was an epic failure. The setback was obviously an unexpected loss of money and time. Valuable lesson learned wouldn’t you think?

Maybe now, he prefers to have the CypCap’s, MCB, and all testing nailed down first before pulling the trigger on a CRO. jmo

Something I tend to think of quite often is that there was a lot of time spent with TD2...a lot. So, it’s highly possible that a lot of the planning and legwork is already complete. Perhaps the new CRO doesn’t really have an enormous amount of work to do. Work that would need to be done at the 11th hour, however.

Look, here you have a CEO of a biotech company who knows he potentially has a disruptive PC therapy. Time is so critical now. Every last step is critical now. I think here in the homestretch to the IND and trial, step by step, he’s trying to be as careful as possible to get us there.

Yeah, we need the CRO, but we need the MCB and CypCap’s more, do we not?

I’m sure we’ll get the CRO, but when? ....your guess is as good as mine.


Keeping the faith and remaining positive.

(((((Patience)))))


Go PharmaCyte!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News